Advertisement
Advertisement
CRSP
CRISPR Therapeutics AG
54.83
USDSponsored
+2.41
+4.60%
May 08, 16:00 UTC -4
Closed
After-Market
54.63
-0.20
-0.36%
CRISPR Therapeutics AG Financial Snapshot
| Market Cap | 5.27B |
| Beta | 1.80 |
| Earnings Per Share (EPS) | -6.52 |
| Price-to-Book (P/B) Ratio | 2.56 |
| Operating Margin | -13827.52% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -26.31% |
| Current Ratio | 13.32% |
| Free Cash Flow | -345.93M |
Trending Stocks
Advertisement